Table 1.
Standard and extended half-life factor replacement products for haemophilia A and B included in this analysis
| Standard half-life products | Extended half-life products |
| Haemophilia A (factor VIII) | |
| Xyntha/ReFacto AF (moroctocog alfa; Pfizer) | Adynovate (rurioctocog alfa pegol; Shire) |
| Advate (octocog alfa; Shire) | Eloctate/Elocta (efmoroctocog alfa; Bioverativ Therapeutics/SOBI) |
| Helixate FS/Helixate NexGen (octocog alfa; CSL Behring) | |
| Kogenate FS/Kogenate (octocog alfa; Bayer HealthCare) | |
| Kovaltry (octocog alfa; Bayer HealthCare) | |
| Recombinate (octocog alfa; Shire) | |
| Nuwiq (simoctocog alfa; Octapharma) | |
| NovoEight (turoctocog alfa; Novo Nordisk) | |
| Haemophilia B (factor IX) | |
| Betafact (nonacog alfa; LFB Biomedicaments) | Alprolix (eftrenonacog alfa; Bioverativ Therapeutics) |
| Immunine VH (human coagulation FIX, vapour heated; Shire) | Idelvion (albutrepenonacog alfa; CSL Behring) |
| Octanine F (human coagulation FIX; Octapharma) | |
| Haemonine (human coagulation FIX; Biotest Pharma) | |
| Berinin P (human coagulation FIX; CSL Behring) | |
| BeneFIX (nonacog alfa; Pfizer) | |
| Rixubis (nonacog gamma; Shire) | |
FIX, factor IX.